ADVOCATH / FLO-CHECK

A Smarter Way to Recognize the Signs of a UTI.

For people who rely on catheters, early signs of a urinary tract infection can be difficult to recognize.

Flo-Check is developing catheter-integrated screening technology designed to bring earlier insight into everyday catheter care.

Explore Our Innovation →
THE NEED. THE INNOVATION. THE OPPORTUNITY.

Better Information. Earlier Insight.
Smarter Catheter Care.

We're developing a new approach to urinary health screening,
designed around the routines people already rely on.

Three friends enjoying time together outdoors at an adaptive recreation event
01 / THE CHALLENGE

Recognizing the Signs

For many catheter users, the early signs of a urinary tract infection can be difficult to recognize, creating uncertainty about when to seek further evaluation.

02 / OUR APPROACH

Screening at the Source

Flo-Check is developing technology that integrates urinary screening into existing catheter-care routines, with the goal of making timely information more accessible.

03 / OUR VISION

Beyond a Single Test

Our long-term vision is a flexible platform capable of supporting additional urinary diagnostics and broader opportunities in catheter-associated care.

THE FLO-CHECK TECHNOLOGY

Screening Built Around the Catheter Routine.

Flo-Check is developing technology designed to make screening for potential urinary tract infections a more natural part of catheter care. Our goal is to give people who rely on catheters a simple visual indication of possible infection-related changes, helping them recognize when further medical evaluation may be needed.

Caregiver assisting an older adult in a healthcare setting
OUR INITIAL FOCUS

Bringing Screening Into Everyday Care

Our first application is designed to make urinary screening more accessible for people who rely on catheters. By fitting into familiar routines, Flo-Check aims to provide meaningful information without adding unnecessary steps to everyday care.

THE NEXT PHASE

Extending Screening Into Clinical Care

Our next phase builds on Flo-Check's foundation, with a planned application for hospitals, long-term care facilities, and other healthcare settings. This expansion is intended to address important challenges in catheter-associated urinary health, where timely information can help inform clinical decisions.

THE LONG-TERM VISION

Beyond a Single Diagnostic Test

Flo-Check represents the beginning of a broader vision for urinary health. We're building on our intellectual property and ongoing development efforts to explore new diagnostic opportunities that could expand the role of screening in catheter care.

Flo-Check has not yet received FDA clearance. Clinical performance and intended uses remain subject to validation and regulatory review.

Protected Innovation. Purposeful Progress.

AdvoCath's Flo-Check technology is supported by a growing intellectual property portfolio, including three issued U.S. patents and one pending patent application.

We are advancing product development, verification and validation, and regulatory planning as we work toward FDA submission and commercialization.

THE STORY BEHIND THE INNOVATION

Driven by Purpose.

For more than 23 years, AdvoCath co-founder Billy Vickers has lived with a spinal cord injury and experienced firsthand the challenges of managing urinary health. Through his work as a peer mentor and advocate, he has seen how widely these challenges affect others in the spinal cord injury community.

Together, Billy and co-founder Christine McDunnough lead Wheels in Motion, a nonprofit serving people with disabilities and veterans. Their shared experiences and deep connection to this community inspired Flo-Check—a practical innovation born from understanding a problem that too often goes unrecognized.

AdvoCath co-founders Billy Vickers and Christine McDunnough
INVESTMENT & STRATEGIC PARTNERSHIPS

Partner With AdvoCath.

We're advancing Flo-Check toward its next development and regulatory milestones, with a focus on bringing meaningful urinary health innovation closer to the people who need it.

AdvoCath welcomes conversations with investors, medical device companies, clinical collaborators, and strategic partners who share our vision for improving catheter-associated care.

Start a Conversation →

Start a Conversation

Name